pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·Aug 3·1 min read
save

Amgen discloses cybersecurity breach affecting patient data

Aug 3, 2026·read at BioSpace ↗RegulatoryNegative

Amgen reported a cybersecurity incident that resulted in the exfiltration of protected patient health information and other proprietary data stored in cloud services managed by third‑party providers. The company disclosed the breach in an SEC filing, describing the unauthorized activity as material due to the volume and sensitivity of the files involved.

Amgen said the breach has not impacted its ability to meet patient needs, nor has it affected financial reporting, manufacturing operations, or product supply. The firm expects no effect on its financial condition.

The company emphasized its commitment to privacy and security, noting that it will make required regulatory and legal notifications as the investigation continues.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “Amgen hit with cybersecurity breach, patient data affected”

read at BioSpace ↗
583 words · retrieved Aug 3
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
AMGEN20NOVO3Novo Nordisk Inc2Ultragenyx Pharmaceutical Inc.2
drugs
avacopan5CorlanorRare Disease
topics
Rare Disease2ApprovalBig PharmaCardiologyHeart FailureNephrologyRecall

related stories

  • 1d agoSionna says good-bye to 46% of staffers, including execBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Aug 35 companies advancing ATTR assets in the wake of Wainua’s failBioSpace
  • Jul 31Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 failFierce Biotech
  • Jul 24Amgen deploys patients to defend troubled Tavneos in FDA hearing requestBioSpace